SecBot SecBot
SECBOTREPLAY Home › Report › OMCL

OMCL · Omnicell reported strong Q1 2026 results with total revenue of $310M…

OMNICELL, INC. · 8-K filed Apr 28, 2026 at 06:36 ET

At the news

BULLISHIMPACT 8/10

8-K filed Apr 28, 2026 at 06:36 ET

Omnicell reported strong Q1 2026 results with total revenue of $310M (+15% YoY), GAAP EPS of $0.25 (vs -$0.15), and non-GAAP EPS of $0.55 (vs $0.26). The company raised full-year 2026 non-GAAP EBITDA and EPS guidance, signaling accelerating profitability and demand for its medication management solutions.

  • Q1 2026 total revenue $310M, up 15% YoY from $270M
  • GAAP net income $11M ($0.25/diluted share) vs loss of $7M (-$0.15)
  • Non-GAAP net income $25M ($0.55/diluted share) vs $12M ($0.26)
  • Operating cash flow $55M, up from $26M YoY

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access